Pekin Hardy Strauss’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.19M Sell
284,980
-3,744
-1% -$61.2K 0.44% 62
2025
Q4
$3.72M Sell
288,724
-137,958
-32% -$1.46M 0.34% 73
2025
Q3
$3.6M Sell
426,682
-10,499
-2% -$99K 0.36% 73
2025
Q2
$3.77M Buy
437,181
+54,100
+14% +$402K 0.43% 63
2025
Q1
$3.31M Sell
383,081
-101,974
-21% -$725K 0.4% 68
2024
Q4
$3.25M Sell
485,055
-11,305
-2% -$84K 0.41% 66
2024
Q3
$3.57M Buy
496,360
+155,157
+45% +$1.43M 0.46% 65
2024
Q2
$3.55M Buy
341,203
+44,740
+15% +$447K 0.49% 62
2024
Q1
$2.98M Buy
296,463
+25,799
+10% +$277K 0.41% 69
2023
Q4
$4.13M Sell
270,664
-13,445
-5% -$186K 0.58% 48
2023
Q3
$3.97M Sell
284,109
-29,985
-10% -$453K 0.63% 47
2023
Q2
$4.16M Buy
314,094
+28,160
+10% +$383K 0.46% 48
2023
Q1
$4.6M Sell
285,934
-29,585
-9% -$523K 0.61% 44
2022
Q4
$4.69M Buy
315,519
+21,848
+7% +$380K 0.65% 45
2022
Q3
$5.84M Buy
293,671
+30,015
+11% +$743K 0.93% 25
2022
Q2
$5.39M Buy
263,656
+700
+0.3% +$17.3K 0.76% 32
2022
Q1
$7.98M Buy
262,956
+4,490
+2% +$176K 0.99% 22
2021
Q4
$10.6M Buy
258,466
+53,415
+26% +$2.22M 1.43% 12
2021
Q3
$8.69M Buy
205,051
+26,040
+15% +$1.29M 1.24% 17
2021
Q2
$9.44M Buy
+179,011
New +$8.9M 1.31% 14
2018
Q4
Sell
-3,750
Closed -$205K 202
2018
Q3
$205K Sell
3,750
-900
-19% -$49.7K 0.04% 185
2018
Q2
$250K Sell
4,650
-244,358
-98% -$12.8M 0.05% 168
2018
Q1
$12.1M Sell
249,008
-251,658
-50% -$10.7M 2.21% 10
2017
Q4
$17M Sell
500,666
-9,762
-2% -$342K 3.09% 6
2017
Q3
$17.3M Sell
510,428
-18,600
-4% -$637K 3.24% 4
2017
Q2
$18.9M Sell
529,028
-354,752
-40% -$12M 2.97% 4
2017
Q1
$25.7M Sell
883,780
-18,558
-2% -$516K 5.03% 3
2016
Q4
$21.7M Buy
902,338
+347,976
+63% +$9.5M 1.94% 4
2016
Q3
$17.2M Buy
554,362
+545,112
+5,893% +$17.2M 2.94% 6
2016
Q2
$271K Sell
9,250
-1,900
-17% -$56.9K 0.06% 132
2016
Q1
$343K Sell
11,150
-6,500
-37% -$168K 0.08% 109
2015
Q4
$473K Sell
17,650
-18,310
-51% -$509K 0.11% 103
2015
Q3
$980K Sell
35,960
-10,650
-23% -$292K 0.22% 73
2015
Q2
$1.28M Buy
46,610
+1,464
+3% +$35.4K 0.25% 66
2015
Q1
$965K Sell
45,146
-19,300
-30% -$330K 0.18% 70
2014
Q4
$1.22M Sell
64,446
-28,510
-31% -$610K 0.18% 107
2014
Q3
$2.03M Sell
92,956
-56,928
-38% -$1.52M 0.35% 43
2014
Q2
$4.84M Sell
149,884
-266,318
-64% -$8.17M 0.76% 31
2014
Q1
$11.9M Sell
416,202
-3,560
-0.8% -$118K 1.94% 19
2013
Q4
$16.5M Sell
419,762
-213,684
-34% -$7.4M 2.56% 16
2013
Q3
$22.1M Sell
633,446
-527,518
-45% -$16.3M 3.5% 12
2013
Q2
$26.2M Buy
+1,160,964
New +$24.7M 4.45% 7

Other funds holding HLF

Pekin Hardy Strauss's HLF Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its Herbalife (HLF) stake by 1.3% in Q1 2026, selling an estimated $61.2K and leaving 284,980 shares worth $4.19M. The position accounts for 0.44% of the portfolio, ranked #62.

Pekin Hardy Strauss first reported a position in HLF in Q2 2013 and has held it in 42 quarters since. The position peaked at $26.2M in Q2 2013. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Pekin Hardy Strauss held 284,980 shares of Herbalife worth $4.19M as of Q1 2026.
  • Pekin Hardy Strauss sold 3,744 Herbalife shares in Q1 2026, an estimated $61.2K.
  • Herbalife made up 0.44% of Pekin Hardy Strauss's portfolio in Q1 2026, its #62 holding.
  • Pekin Hardy Strauss first reported a position in Herbalife in Q2 2013 and has held it in 42 quarters since.
  • Pekin Hardy Strauss's Herbalife position peaked at $26.2M in Q2 2013.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.